Skip to Content
  1. All Products
  2. 2024
  3. Zheijiang Guobang Pharmaceuticals, China, 2025
-
Zheijiang Guobang Pharmaceuticals, China, 2025

Zheijiang Guobang Pharmaceuticals, China, 2025

https://www.myauditor.nl/web/image/product.template/1071/image_1920?unique=7f3de77

GMP Audit Report

Company
Zheijiang Guobang Pharmaceuticals

Product(s)
diclazuril, enrofloxacine, marbofloxacine

Country
China

Audit Year
2025


0.00 € 0.0 EUR 0.00 €

0.00 €

This combination does not exist.

Request Quotation
Diclazuril Enrofloxacine Marbofloxacin

 

Share